Primary Device ID | 04250289504935 |
NIH Device Record Key | 68b6b153-ddc6-4cef-b0d5-2e34083ae028 |
Commercial Distribution Status | In Commercial Distribution |
Brand Name | AESKUSLIDES® ANA-HEp-2 gamma |
Version Model Number | 51.101.US |
Catalog Number | 51.101.US |
Company DUNS | 341714388 |
Company Name | Aesku.Diagnostics GmbH & Co. KG |
Device Count | 1 |
DM Exempt | false |
Pre-market Exempt | false |
MRI Safety Status | Labeling does not contain MRI Safety Information |
Human Cell/Tissue Product | false |
Device Kit | true |
Device Combination Product | false |
Single Use | true |
Lot Batch | true |
Serial Number | false |
Manufacturing Date | false |
Expiration Date | true |
Donation Id Number | false |
Contains Natural Rubber Latex | false |
Labeled No Natural Rubber Latex | false |
RX Perscription | false |
OTC Over-The-Counter | false |
Device Issuing Agency | Device ID |
---|---|
GS1 | 04250289504935 [Primary] |
DHN | Antinuclear Antibody, Indirect Immunofluorescent, Antigen, Control |
Steralize Prior To Use | false |
Device Is Sterile | false |
Public Version Status | Update |
Device Record Status | Published |
Public Version Number | 3 |
Public Version Date | 2018-07-06 |
Device Publish Date | 2017-02-28 |
04250289513531 - HELMED® Automated IFA Processor | 2025-01-13 |
04260186120008 - HELIOS® Automated IFA System | 2025-01-13 |
04250289513401 - AESKUSLIDES® nDNA (Crithidia luciliae) | 2024-11-25 AESKUSLIDES® nDNA (Crithidia luciliae) is an indirect immunofluorescence assay utilizing Crithidia luciliae coated slides as a |
04250289512909 - HERA | 2023-07-28 |
04250289512541 - HELIOS® AUTOMATED IFA SYSTEM | 2023-07-03 |
04250289512565 - HELMED® AUTOMATED IFA PROCESSOR | 2023-07-03 |
04250289500005 - AESKUSLIDES® ANA-HEp-2 | 2018-07-06 AESKUSLIDES ANA-HEp-2 is an indirect immunofluorescence assay to detect nuclear and / or cytoplasmic autoantibodies in human ser |
04250289500425 - AESKULISA® ANA-8Pro | 2018-07-06 AESKULISA ANA-8Pro is a solid phase enzyme immunoassay for the separate qualitative detection of IgG antibodies against eight ce |